Efficacy and Safety of Tofacitinib in Subjects With Active Ankylosing Spondylitis (AS)
Clinical trial NCT03502616 · COMPLETED
Trial details
- NCT number
- NCT03502616
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-07
- Primary completion
- 2019-12-19
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.